ACLS Flashcards
(70 cards)
1
Q
What is the first sign of deterioration in a patient who might progress into cardiac arrest?
A
Agonal breaths
vvvvvvvvvvvvvvv
Agonal breaths, also known as agonal respirations, are labored, gasping breaths that are a sign of a severe medical emergency. They can sound like snoring, snorting, or moaning.
2
Q
The most common cause of out-of-hospital sudden cardiac arrest in adults is ventricular tachycardia or fibrillation, often due to acute myocardial ischemia or infarction. What is the most significant factor that affects survival?
A
Time to defibrillation is the most important factor affecting survival.
3
Q
What is this rhythm?
A
Normal sinus rhythm
4
Q
You see this rhythm, but there is no pulse, what’s the issue?
A
Pulseless electrical activity (PEA).
5
Q
What is this rhythm?
A
Sinus Tachycardia. To estimate the HR, divide 300 by the number of big boxes between QRS complexes.
6
Q
What is this rhythm?
A
Sinus Bradycardia
Treated with Atropine (1 mg at the first dose) when there are symptoms of hypotension (syncope or altered mental status) or shock.
7
Q
What is this rhythm?
A
Sinus Bradycardia
Treated with signs of hypotension with Atropine (1 mg at the first dose).
8
Q
Your patient is a 56-year-old woman with a history of type 2 diabetes who reports feeling dizzy. She is pale and diaphoretic. Her blood pressure is 80/60 mm Hg. The cardiac monitor documents the rhythm shown here. She is receiving oxygen at 4 L/min by nasal cannula, and an IV has been established. What do you administer next?
A. Atropine 1 mg IV
B. Morphine sulfate 4 mg IV
C. Dopamine at 2 to 10 mcg/kg per minute
D. Glucose 50% V push
A
A. Atropine 1 mg IV
9
Q
What do you do in an instance where a patient has bradycardia and signs of hypotension, shock, or diaphoresis, and they have a history of glaucoma (and you can’t give atropine), what do you do?
A
Glucagon, EPI, or transcutaneous pacing.
10
Q
What is this rhythm?
A
Second-degree atrioventricular block (Mobitz type I; Wenckebach)
11
Q
What is this rhythm?
A
Second-degree atrioventricular block (Mobitz I Wenckebach)
12
Q
What is this rhythm?
A
Second-degree atrioventricular block (Mobitz I Wenckebach)
13
Q
What is this rhythm?
A
Second-degree atrioventricular block (Mobitz type Il block)
14
Q
What is this rhythm?
A
Second-degree atrioventricular block (Mobitz type II Wenckebach)
15
Q
What is this rhythm?
A
Third-degree atrioventricular block
16
Q
What is this rhythm?
A
SVT
17
Q
What is this rhythm?
A
SVT
18
Q
A 45-year-old woman with a history of palpitations develops light-headedness and palpitations. She has received adenosine 6 mg IV for the rhythm shown here, without conversion of the rhythm. She is now extremely apprehensive. Her blood pressure is 128/70 mm Hg. What is the next appropriate intervention?
A. Perform vagal maneuvers
B. Perform unsynchronized cardioversion
C. Perform synchronized cardioversion
D. Administer adenosine 12 mg IV
A
D. Administer adenosine 12 mg IV
19
Q
What is this rhythm?
A
Monomorphic ventricular tachycardia
20
Q
What is this rhythm?
A
Polymorphic ventricular tachycardia
21
Q
A patient has been resuscitated from cardiac arrest. During post-ROSC treatment, the patient becomes unresponsive, with the rhythm shown here. Which action is indicated next?
A. Give an immediate unsynchronized high-energy shock (defibrillation dose)
B. Give lidocaine 1 to 1.5 mg/kg IV
C. Perform synchronized cardioversion
D. Repeat amiodarone 300 mg IV
A
A. Give an immediate unsynchronized high-energy shock (defibrillation dose)
22
Q
What is this rhythm?
A
V Fib
23
Q
What is this rhythm?
A
V Fib
24
Q
What is this rhythm?
A
V Fib
25
After initiation of CPR and 1 shock for ventricular fibrillation, this rhythm is present on the next rhythm check. A second shock is given, and chest compressions are resumed immediately.
An IV is in place, and no drugs have been given. Bag-mask ventilations are producing visible chest rise. What is your next intervention?
A. Administer 3 sequential (stacked) shocks at 320 J (monophasic defibrillator)
B. Give amiodarone 300 mg IV/O
C. Intubate and administer 100% oxygen
D. Give epinephrine 1 mg IV/IO
D. Give epinephrine 1 mg IV/IO
26
What is this rhythm?
A Fib
27
What is this rhythm?
Atrial flutter
28
What is this rhythm?
PEA
29
What is the first step in PEA?
Compressions --> Airway --> IV/IO --> EPI every 3-5 minutes
30
What are the reversible causes of PEA and asystole?
5 Ts and 5 Hs.
31
What is this rhythm?
Agonal rhythm/asystole
The intervention to give compressions and epinephrine.
32
A patient was in refractory ventricular fibrillation. A third shock has just been administered. Your team looks to you for instructions. What is your next action?
A. Check the carotid pulse
B. Give amiodarone 300 mg V
C. Give atropine 1 mg IV
D. Resume high-quality chest compressions
D. Resume high-quality chest compressions
33
You arrive on the scene with the code team. High-quality CPR is in progress. An AED has previously advised "no shock indicated." A rhythm check now finds asystole. After resuming high-quality compressions, which action do you take next?
Choose the correct option and select submit.
A. Call for a pulse check
B. Insert a laryngeal airway
C. Establish IV or IO access
D. Perform endotracheal intubation
C. Establish IV or IO access
34
A patient with possible STEMI has ongoing chest discomfort. What is a contraindication to nitrate administration?
Choose the correct option and select submit.
A. Heart rate less than 90/min
B. Systolic blood pressure greater than 180 mm Hg
C. Anterior wall myocardial infarction
D. Use of a phosphodiesterase inhibitor within the previous 24 hours
D. Use of a phosphodiesterase inhibitor within the previous 24 hours
35
A monitored patient in the ICU developed a sudden onset of narrow-complex tachycardia at a rate of 220/min. The patient's blood pressure is 128/58 mm Hg, the PETCO is 38 mm Hg, and the pulse oximetry reading is 98%. There is vascular access in the left arm, and the patient has not been given any vasoactive drugs. A 12-lead ECG confirms a supraventricular tachycardia with no evidence of ischemia or infarction. The heart rate has not responded to vagal maneuvers. What is your next action?
Choose the correct option and select submit.
A. Administer amiodarone 300 mg IV push
B. Perform synchronized cardioversion at 50 J
C. Administer adenosine 6 mg IV push
D. Perform synchronized cardioversion at 200 J
C. Administer adenosine 6 mg IV push
36
What are the shockable rhythms?
ventricular fibrillation and pulseless ventricular tachycardia.
37
A patient is in refractory ventricular fibrillation and has received multiple appropriate defibrillation shocks, epinephrine 1 mg IV twice, and an initial dose of amiodarone 300 mg IV. The patient is intubated. Which best describes the recommended second dose of amiodarone for this patient?
A. 1 mg/kg IV push
B. 300 mg IV push
C. 150 mg IV push
D. 1 to 2 mg/min infusion
The recommended second dose of amiodarone for a patient in refractory ventricular fibrillation who has already received an initial dose of 300 mg IV is 150 mg IV push. This is in accordance with Advanced Cardiac Life Support (ACLS) guidelines for the management of ventricular fibrillation resistant to initial treatment.
Therefore, the correct option is:
C. 150 mg IV push
38
What is the indication for the use of magnesium in cardiac arrest?
A. Shock-refractory monomorphic ventricular tachycardia
B. Pulseless ventricular tachycardia-associated torsades de pointes
C. Shock-refractory ventricular fibrillation
D. Ventricular tachycardia associated with a normal QT interval
Magnesium is indicated for use in cardiac arrest specifically for cases of torsades de pointes, a type of polymorphic ventricular tachycardia that often occurs in the context of a prolonged QT interval. It is used when torsades de pointes is suspected or confirmed, especially if it is causing a pulseless ventricular tachycardia.
Therefore, the correct option is:
B. Pulseless ventricular tachycardia-associated torsades de pointes
39
A patient with sinus bradycardia and a heart rate of 42/min has diaphoresis and a blood pressure of 80/60 mm Hg. What is the initial dose of atropine?
A. 0.5 mg
B. 3 mg
C. 0.1 mg
D. 1 mg
D. 1 mg
40
A patient has a rapid irregular wide-complex tachycardia. The ventricular rate is 138/min. He is asymptomatic, with a blood pressure of 110/70 mm
Hg. He has a history of angina. What action is recommended next?
A. Giving adenosine 6 mg IV bolus
B. Giving lidocaine 1 to 1.5 mg IV bolus
C. Performing synchronized cardioversion
D. Seeking expert consultation
For a patient presenting with a rapid irregular wide-complex tachycardia, and being asymptomatic with a stable blood pressure, the initial management should be focused on diagnosing the rhythm accurately and understanding the underlying cause. Given the complexity of wide-complex tachycardias and the patient's history of angina, this could be ventricular tachycardia or a supraventricular tachycardia with aberrancy.
Since the patient is hemodynamically stable and asymptomatic, there is not an immediate need for interventions like adenosine, lidocaine, or synchronized cardioversion, which are more urgent in unstable situations. Instead, the recommended action is to seek expert consultation to determine the most appropriate intervention, especially to distinguish between ventricular and supraventricular origins of the tachycardia and to guide subsequent management.
Therefore, the correct option is:
D. Seeking expert consultation
41
A 62-year-old man suddenly experienced difficulty speaking and left-sided weakness. He meets initial criteria for fibrinolytic therapy, and a CT scan of the brain is ordered. Which best describes the guidelines for antiplatelet and fibrinolytic therapy?
A. Give aspirin 120 mg and clopidogrel 75 mg orally
B. Give heparin if the CT scan is negative for hemorrhage
C. Hold aspirin for at least 24 hours if rtPA is administered
D. Give aspirin 162 to 325 mg to be chewed immediately
In the scenario described, where a patient presents with symptoms suggestive of an acute ischemic stroke and is being considered for fibrinolytic therapy (e.g., rtPA, recombinant tissue plasminogen activator), the guidelines recommend careful management of concurrent medications that could increase bleeding risk.
It is specifically recommended that antiplatelet therapy, such as aspirin, should be withheld for at least 24 hours after the administration of rtPA. This is to avoid increasing the risk of bleeding, which is a significant concern when using fibrinolytic therapy. The patient should not receive aspirin or other antiplatelets immediately if fibrinolytic therapy is given, until it is confirmed that there is no bleeding complication post-thrombolysis.
Therefore, the correct option is:
C. Hold aspirin for at least 24 hours if rtPA is administered
42
A 35-year-old woman has palpitations, light-headedness, and a stable tachycardia. The monitor shows a regular narrow-complex QRS at a rate of 180/min. Vagal maneuvers have not been effective in terminating the rhythm. An IV has been established. Which drug should be administered?
A. Epinephrine 2 to 10 mcg/kg per minute
B. Lidocaine 1 mg/kg
C. Atropine 0.5 mg
D. Adenosine 6 mg
For a patient exhibiting symptoms like palpitations and light-headedness with a stable, regular narrow-complex tachycardia, where vagal maneuvers have been ineffective, the appropriate drug to administer is adenosine. Adenosine is effective for terminating certain types of supraventricular tachycardia (SVT), which often present with a narrow complex QRS pattern. The initial dose of adenosine recommended is 6 mg given rapidly as an intravenous (IV) bolus, followed by a saline flush.
Therefore, the correct option is:
D. Adenosine 6 mg
43
A patient with possible STEMI has ongoing chest discomfort. What is a contraindication to nitrate administration?
A. Use of a phosphodiesterase inhibitor within the previous 24 hours
B. Heart rate less than 90/min
C. Anterior wall myocardial infarction
D. Systolic blood pressure greater than 180 mm Hg
One of the contraindications to the administration of nitrates, such as nitroglycerin, in the setting of acute myocardial infarction (AMI) or chest pain is the recent use of phosphodiesterase inhibitors. Phosphodiesterase inhibitors are commonly used for erectile dysfunction and can cause severe hypotension when combined with nitrates due to their synergistic effect on vascular smooth muscle relaxation.
Therefore, the correct option is:
A. Use of a phosphodiesterase inhibitor within the previous 24 hours
44
A patient is in cardiac arrest. Ventricular fibrillation has been refractory to a second shock. Which drug should be administered first?
A. Sodium bicarbonate 50 mEq IV/IO
B. Lidocaine 1 mg/kg IV/10
C. Epinephrine 1 mg IV/IO
D. Atropine 1 mg IV/IO
In the management of cardiac arrest with refractory ventricular fibrillation, epinephrine is the first drug recommended after initial defibrillation attempts have failed. According to Advanced Cardiac Life Support (ACLS) guidelines, epinephrine should be administered at a dose of 1 mg IV/IO, which can be repeated every 3-5 minutes during the resuscitation effort.
Therefore, the correct option is:
C. Epinephrine 1 mg IV/IO
45
A patient is in cardiac arrest. High-quality chest compressions are being given. The patient is intubated, and an IV has been started. The rhythm is asystole. What is the first drug/dose to administer?
A. Epinephrine 1 mg IV/IO
B. Atropine 1 mg V/lo
C. Atropine 0.5 mg IV/IO
D. Dopamine 2 to 20 mcg/kg per minute IV/IO
In the case of cardiac arrest where the rhythm is asystole, the first drug and dose to administer according to current Advanced Cardiac Life Support (ACLS) guidelines is epinephrine. The recommended dose is 1 mg administered intravenously or intraosseously (IV/IO), and this can be repeated every 3-5 minutes during resuscitation.
Therefore, the correct option is:
A. Epinephrine 1 mg IV/IO
46
A patient is in pulseless ventricular tachycardia. Two shocks and 1 dose of epinephrine have been given. Which drug should be given next?
A. Amiodarone 300 mg
B. Epinephrine 3 mg
C. Adenosine 6 mg
D. Lidocaine 0.5 mg/kg
For a patient in pulseless ventricular tachycardia who has already received two shocks and one dose of epinephrine, the next recommended drug according to Advanced Cardiac Life Support (ACLS) guidelines is amiodarone. The initial dose of amiodarone for this scenario is 300 mg IV/IO.
Therefore, the correct option is:
A. Amiodarone 300 mg
47
You arrive on the scene with the code team. High-quality CPR is in progress. An AED has previously advised "no shock indicated." A rhythm check now finds asystole. After resuming high-quality compressions, which action do you take next?
Choose the correct option and select submit.
A. Establish IV or 10 access
B. Insert a laryngeal airway
C. Perform endotracheal intubation
D. Call for a pulse check
In the situation described where high-quality CPR is ongoing and the AED has previously advised "no shock indicated" with a rhythm check revealing asystole, the next step after resuming compressions is to ensure that there is a secure route for medication administration and advanced airway management if needed. Establishing intravenous (IV) or intraosseous (IO) access is crucial for administering necessary medications such as epinephrine during cardiac arrest management.
Therefore, the correct option is:
A. Establish IV or IO access
48
A patient is in refractory ventricular fibrillation. High-quality CPR is in progress. One dose of epinephrine was given after the second shock. An antiarrhythmic drug was given immediately after the third shock. You are the team leader. Which medication do you order next?
A. Epinephrine 1 mg
B. Sodium bicarbonate 50 mEq
C. A second dose of the antiarrhythmic drug
D. Epinephrine 3 mg
In the scenario of refractory ventricular fibrillation where high-quality CPR is in progress, and one dose of epinephrine and an antiarrhythmic drug have already been administered following the appropriate shocks, the next step in the Advanced Cardiac Life Support (ACLS) algorithm would be to continue with the administration of epinephrine every 3-5 minutes. Since epinephrine was given after the second shock, and assuming sufficient time has passed or an additional shock has been given without return of spontaneous circulation, the next appropriate action would be to administer another dose of epinephrine.
Therefore, the correct option is:
A. Epinephrine 1 mg
49
A patient with STEMI has ongoing chest discomfort. Heparin 4000 units IV bolus and a heparin infusion of 1000 units per hour are being administered. The patient did not take aspirin because he has a history of gastritis, which was treated 5 years ago. What is your next action?
A. Give clopidogrel 300 mg orally
B. Give enteric-coated aspirin 325 mg rectally
C. Give enteric-coated aspirin 75 mg orally
D. Give aspirin 162 to 325 mg to chew
In the management of STEMI, aspirin is a cornerstone treatment because it rapidly inhibits platelet aggregation and reduces the risk of thrombus formation, which is vital in the acute phase of myocardial infarction. Even though the patient has a history of gastritis, the urgent need to manage the STEMI outweighs the potential risks associated with aspirin intake, especially since the gastritis was treated 5 years ago. The best form of aspirin to administer in this scenario to ensure rapid onset of action is to have the patient chew non-enteric coated aspirin.
Therefore, the correct option is:
D. Give aspirin 162 to 325 mg to chew
50
A monitored patient in the ICU developed a sudden onset of narrow-complex tachycardia at a rate of 220/min. The patient's blood pressure is 128/58 mm Hg, the PETCO is 38 mm Hg, and the pulse oximetry reading is 98%. There is vascular access in the left arm, and the patient has not been given any vasoactive drugs. A 12-lead ECG confirms a supraventricular tachycardia with no evidence of ischemia or infarction. The heart rate has not responded to vagal maneuvers. What is your next action?
A. Administer amiodarone 300 mg V push
B. Perform synchronized cardioversion at 50 J
C. Administer adenosine 6 mg V push
D. Perform synchronized cardioversion at 200 J
Given the scenario where the patient in the ICU develops a narrow-complex tachycardia confirmed as supraventricular tachycardia (SVT) on a 12-lead ECG, and vagal maneuvers have failed to terminate the tachycardia, the next step in the management would typically involve pharmacologic intervention. Adenosine is the drug of choice for terminating SVT due to its ability to transiently block the AV node, which can break the reentrant circuit common in SVTs.
The initial recommended dose of adenosine for SVT is 6 mg given rapidly as an IV push, followed by a rapid saline flush. If the initial dose does not convert the rhythm, a subsequent 12 mg dose may be given.
Therefore, the correct option is:
C. Administer adenosine 6 mg IV push
51
A 57-year-old woman has palpitations, chest discomfort, and tachycardia. The monitor shows a regular wide-complex QRS at a rate of 180/min. She becomes diaphoretic, and her blood pressure is 80/60 mm Hg. Which action do you take next?
A. Seek expert consultation
B. Obtain a 12-lead ECG
C. Perform electrical cardioversion
D. Establish V access
In the case of a 57-year-old woman who presents with palpitations, chest discomfort, and a regular wide-complex tachycardia at a rate of 180/min, becoming diaphoretic and hypotensive indicates hemodynamic instability. When a patient exhibits signs of instability with a wide-complex tachycardia, which could be ventricular tachycardia or supraventricular tachycardia with aberrancy, immediate action is required to stabilize the patient.
Given her low blood pressure and symptoms, the most appropriate and urgent intervention is electrical cardioversion. This approach is recommended for hemodynamically unstable patients with ventricular tachycardia or other uncertain wide-complex tachycardias.
Therefore, the correct option is:
C. Perform electrical cardioversion
52
A patient has sinus bradycardia with a heart rate of 36/min. Atropine has been administered to a total dose of 3 mg. A transcutaneous pacemaker has failed to capture. The patient is confused, and her blood pressure is 88/56 mm Hg. Which therapy is now indicated?
A. Atropine 1 mg
B. Normal saline 250 mL to 500 mL bolus
C. Epinephrine 2 to 10 mcg/min
D. Adenosine 6 mg
In the situation described, where a patient has sinus bradycardia with a significantly low heart rate, atropine has been maximally dosed, and transcutaneous pacing has failed to capture, the patient remains symptomatic and hemodynamically unstable. In this scenario, pharmacological support to increase heart rate and improve hemodynamic status is required.
Given the failure of atropine and pacemaker, the best next step is to administer a continuous infusion of a chronotropic agent such as epinephrine. Epinephrine will help increase the heart rate and can also support blood pressure.
Therefore, the correct option is:
C. Epinephrine 2 to 10 mcg/min
53
You are caring for a 66-year-old man with a history of a large intracerebral hemorrhage 2 months ago. He is being evaluated for another acute stroke. The CT scan is negative for hemorrhage. The patient is receiving oxygen via nasal cannula at 2 L/min, and an IV has been established. His blood pressure is 180/100 mm Hg. Which drug do you anticipate giving to this patient?
A. Nicardipine
B. rtPA
C. Aspirin
D. Glucose (D50)
B. Aspirin
In the setting where the patient has a history of a previous intracerebral hemorrhage and a current CT scan that shows no fresh hemorrhage, aspirin can be considered for secondary prevention of ischemic stroke, assuming he's being evaluated for an ischemic stroke and there are no current indications for thrombolytics like rtPA. Aspirin is commonly used in the management of ischemic stroke for its antiplatelet properties, which help prevent clot formation. This can be crucial after an ischemic stroke is confirmed and there's no risk of hemorrhage as shown by the CT scan. If the situation involves managing stroke risk post-discharge or in a longer-term setting where acute hemorrhagic risk is not an issue, aspirin is an appropriate and common choice.
54
A patient is in cardiac arrest. Ventricular fibrillation has been refractory to an initial shock. If no pathway for medication administration is in place, which method is preferred?
A. Endotracheal tube
B. Central line
C. IV or 10
D. External jugular vein
In the scenario of a cardiac arrest where ventricular fibrillation has been refractory to an initial shock and there is no existing pathway for medication administration, the preferred method to quickly establish a route for drug administration is through an intravenous (IV) or intraosseous (IO) line. These methods provide rapid and reliable access for the administration of emergency medications like epinephrine and amiodarone, which are crucial in the management of cardiac arrest.
C. IV or IO is the correct option because it offers the fastest and most effective means of delivering lifesaving medications directly into the circulation.
55
After initiation of CPR and 1 shock for ventricular fibrillation, this rhythm is present on the next rhythm check. A second shock is given, and chest compressions are resumed immediately. An IV is in place, and no drugs have been given. Bag-mask ventilations are producing visible chest rise.
What is your next intervention?
A. Administer 3 sequential (stacked) shocks at 320 J (monophasic defibrillator)
B. Give amiodarone 300 mg IV/IO
C. Intubate and administer 100% oxygen
D. Give epinephrine 1 mg IV/IO
D. Give epinephrine 1 mg IV/IO
56
A patient has been resuscitated from cardiac arrest. During post-ROSC treatment, the patient becomes unresponsive, with the rhythm shown here.
Which action is indicated next?
A. Perform synchronized cardioversion
B. Give lidocaine 1 to 1.5 mg/kg IV
C. Give an immediate unsynchronized high-energy shock (defibrillation dose)
D. Repeat amiodarone 300 mg IV
C. Give an immediate unsynchronized high-energy shock (defibrillation dose)
57
A 35-year-old woman presents with a chief complaint of palpitations. She has no chest discomfort, shortness of breath, or light-headedness. Her blood pressure is 120/78 mm Hg. Which intervention is indicated first?
A. Adenosine 12 mg IV slow push (over 1 to 2 minutes)
B. Vagal maneuvers
C. Metoprolol 5 mg IV and repeat if necessary
D. Adenosine 3 mg IV bolus
B. Vagal maneuvers
58
A patient becomes unresponsive. You are uncertain if a faint pulse is present. The rhythm shown here is seen on the cardiac monitor. An IV is in place. Which action do
you take next?
A. Administer atropine 1 mg
B. Begin transcutaneous pacing
C. Administer epinephrine 1 mg IV
D. Start high-quality CPR
D. Start high-quality CPR
59
You arrive on the scene to find CPR in progress. Nursing staff report the patient was recovering from a pulmonary embolism and suddenly collapsed. Two shocks have been delivered, and an IV has been initiated. What do you administer now?
A. Endotracheal intubation
B. Atropine 0.5 mg IV
C. Epinephrine 1 mg IV
D. Transcutaneous pacing
C. Epinephrine 1 mg IV
60
After providing a shock, the provider should:
A. Resume chest compressions
B. Prepare to deliver a second shock
C. Check the pulse rate
D. Start rescue breathing
A. Resume chest compressions
61
Your patient is not responsive and is not breathing. You can palpate a carotid pulse. Which action do you take next?
Choose the correct option and select submit.
A. Obtain a 12-lead ECG
B. Start rescue breathing
C. Apply an AED
D. Start an IV
B. Start rescue breathing
62
A patient was in refractory ventricular fibrillation. A third shock has just been administered. Your team looks to you for instructions. What is your next action?
A. Give atropine 1 mg IV
B. Give amiodarone 300 mg IV
C. Check the carotid pulse
D. Resume high-quality chest compressions
D. Resume high-quality chest compressions
63
A patient's 12-lead ECG is transmitted by the paramedics and shows a STEMI. When the patient arrives in the emergency department, the rhythm shown here is seen on the cardiac monitor. The patient has resolution of moderate (5/10) chest pain after 3 doses of sublingual nitroglycerin. Blood pressure is 104/70 mm Hg. Which intervention is most important in reducing this patient's in-hospital and 30-day mortality rate?
A. Reperfusion therapy
B. Nitroglycerin administration
C. Atropine administration
D. Application of transcutaneous pacemaker
A. Reperfusion therapy
64
A patient is in cardiac arrest. Ventricular fibrillation has been refractory to an initial shock. If no pathway for medication administration is in place, which method is preferred?
Choose the correct option and select submit.
A. Endotracheal tube
B. External jugular vein
C. Central line
D. IV or IO
D. IV or IO
65
All I/O meds should be followed by ... ?
medications are followed with a flush of 5 to 10 mL of normal saline.
66
IO is mainly used for short-term or long-term?
Short-term, generally less than 24 hours.
67
What are appropriate IO sites in adults?
Proximal Tibia (Most Common)
Landmark: About 2 cm below the tibial tuberosity on the flat anteromedial surface.
Advantages: Easily accessible, large marrow cavity, minimal overlying soft tissue.
Common in: Both adults and pediatrics.
68
What are appropriate IO sites in pediatrics?
- Proximal Humerus (Greater tubercle, about 1-2 cm lateral to the bicipital groove). Advantages are rapid absorption into central circulation, preferred in adults if no contraindications.
- Distal Tibia (3 cm proximal to the medial malleolus, at the midline of the tibia).
Sternum (Manubrium). The advantages is that it provides for rapid central circulation access. Common used in military and prehospital settings, typically using specialized IO devices (e.g., FAST1).
Distal Femur (Midline, just proximal to the patella). The advantage is that it is a large marrow space in younger children.
69
What should be done if there is resistance following an IO insertion?
Bolus administration or an infusion pump should help with resistance to infusion.
70
What are the major contraindications for IO?
- Fractures and crush injuries near the access site
- Conditions with fragile bones
- Previous attempts in the same bone
- Infection
